Literature DB >> 6225022

Erythrocyte C3b receptors in juvenile rheumatoid arthritis.

A L Mäkelä, E Eerola, O P Lehtonen, P Ruuska, R Lantto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6225022     DOI： 10.1056/NEJM198309153091123

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Erythrocyte complement receptor type 1 in non-SLE rheumatic diseases.

Authors:  J H Yen; H W Liu; S F Lin; T P Chen
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?

Authors:  P E Ruuska; I Ikäheimo; S Silvennoinen-Kassinen; M L Käär; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.

Authors:  P Ruuska; J Ilonen; A Mustonen; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.

Authors:  A Kumar; A N Malaviya; S Sinha; P S Khandekar; K Banerjee; L M Srivastava
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?

Authors:  R Lahesmaa; E Eerola; A Toivanen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

7.  Chronic myelocytic leukaemia: HLA association and decreased erythrocyte C3b receptor expression.

Authors:  P Ruuska; S Silvennoinen-Kassinen; T Timonen; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.